scholarly article | Q13442814 |
P356 | DOI | 10.1136/JMG.2008.058701 |
P8608 | Fatcat ID | release_c532smjlrnbcfgfg4sjzucrxny |
P932 | PMC publication ID | 3071570 |
P698 | PubMed publication ID | 18628315 |
P5875 | ResearchGate publication ID | 51403229 |
P50 | author | Andrew Oliver Mungo Wilkie | Q21165202 |
P2093 | author name string | H G Brunner | |
R Pfundt | |||
C E Schwartz | |||
J M Garrett | |||
J A Hurst | |||
T M Strom | |||
E Rossi | |||
B B A de Vries | |||
S Aradhya | |||
O Zuffardi | |||
A Rauch | |||
M J M Nowaczyk | |||
R Ciccone | |||
H Stewart | |||
C Rosenberg | |||
K Bell | |||
A Goldenberg | |||
B Grisart | |||
G M S Mancini | |||
M Field | |||
E E Eichler | |||
J A Veltman | |||
P Saugier-Veber | |||
A M Vianna-Morgante | |||
A J Sharp | |||
A Hackett | |||
M Zenker | |||
D A Koolen | |||
S Crosby | |||
L Willatt | |||
N Van der Aa | |||
S J L Knight | |||
L E L M Vissers | |||
H V Firth | |||
A C Krepischi-Santos | |||
A Destrée | |||
A O M Wilkie | |||
C Shaw-Smith | |||
J Wagenstaller | |||
L L Antonacci-Fulton | |||
L Rooms | |||
M A Manning | |||
M A Wiechert | |||
M D McLellan | |||
M De Gregori | |||
P J Poddighe | |||
S M Price | |||
T L Miner | |||
P2860 | cites work | Structural variation in the human genome | Q22122017 |
UBE3A/E6-AP mutations cause Angelman syndrome | Q24311799 | ||
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification | Q24530153 | ||
Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features | Q24675632 | ||
Segmental duplications and copy-number variation in the human genome | Q28253048 | ||
Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability | Q28257488 | ||
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 | Q28274687 | ||
Genome architecture, rearrangements and genomic disorders | Q29614721 | ||
A common inversion under selection in Europeans | Q29614908 | ||
PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing | Q29618564 | ||
PolyScan: an automatic indel and SNP detection approach to the analysis of human resequencing data | Q31108463 | ||
High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs | Q34106761 | ||
Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. | Q34439696 | ||
A 17q21.31 microdeletion encompassing the MAPT gene in a mentally impaired patient. | Q34529384 | ||
Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome | Q34556894 | ||
A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. | Q34556905 | ||
The natural history of Noonan syndrome: a long-term follow-up study | Q34567819 | ||
A 17q21.31 microduplication, reciprocal to the newly described 17q21.31 microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features | Q34638615 | ||
The epidemiology of mental retardation: challenges and opportunities in the new millennium | Q34821968 | ||
Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group | Q35249493 | ||
Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration | Q35447435 | ||
Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements | Q36360406 | ||
Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation | Q36430804 | ||
Whole genome DNA copy number changes identified by high density oligonucleotide arrays | Q36475181 | ||
A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures | Q36627230 | ||
Diagnosis and management of medical problems in adults with Williams-Beuren syndrome | Q36886033 | ||
Molecular karyotyping in patients with mental retardation using 100K single-nucleotide polymorphism arrays | Q37004613 | ||
A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays | Q40396914 | ||
The prevalence of mental retardation: a critical review of recent literature. | Q41376660 | ||
Association of an extended haplotype in the tau gene with progressive supranuclear palsy | Q47726308 | ||
Genome structural variation and sporadic disease traits | Q48085036 | ||
Mutations in RAI1 associated with Smith-Magenis syndrome | Q48254701 | ||
Pick's disease is associated with mutations in the tau gene. | Q49153118 | ||
Clinical features and management issues in Mowat-Wilson syndrome. | Q51910142 | ||
Simple detection of genomic microdeletions and microduplications using QMPSF in patients with idiopathic mental retardation. | Q51916075 | ||
Whole-genome array-CGH identifies novel contiguous gene deletions and duplications associated with developmental delay, mental retardation, and dysmorphic features. | Q51983225 | ||
The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. | Q53270733 | ||
Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. | Q53338420 | ||
Development and validation of a CGH microarray for clinical cytogenetic diagnosis | Q57537935 | ||
Two-color multiplex ligation-dependent probe amplification: Detecting genomic rearrangements in hereditary multiple exostoses | Q62937182 | ||
Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits | Q77572380 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microdeletion syndrome | Q10329580 |
P304 | page(s) | 710-20 | |
P577 | publication date | 2008-11-01 | |
P1433 | published in | Journal of Medical Genetics | Q14640281 |
P1476 | title | Clinical and molecular delineation of the 17q21.31 microdeletion syndrome | |
P478 | volume | 45 |
Q37691480 | "Idiopathic" mental retardation and new chromosomal abnormalities |
Q40182646 | A New Case of the Rare 10q22.3q23.2 Microdeletion Flanked by Low-Copy Repeats 3/4. |
Q37598586 | A case of 17q21.31 microduplication and 7q31.33 microdeletion, associated with developmental delay, microcephaly, and mild dysmorphic features. |
Q53551115 | An additional clinical sign of 17q21.31 microdeletion syndrome: preaxial polydactyly of hands with broad thumbs. |
Q34009396 | Array-CGH analysis in Rwandan patients presenting development delay/intellectual disability with multiple congenital anomalies |
Q57828426 | Array-based MLPA to detect recurrent copy number variations in patients with idiopathic mental retardation |
Q24632941 | CNV and nervous system diseases--what's new? |
Q37239862 | Characterization of six human disease-associated inversion polymorphisms |
Q36744802 | Common variants at 6q22 and 17q21 are associated with intracranial volume |
Q33856401 | Comparison of genome-wide array genomic hybridization platforms for the detection of copy number variants in idiopathic mental retardation |
Q42210110 | Complex phenotype associated with 17q21.31 microdeletion. |
Q37408049 | Complex segmental duplications mediate a recurrent dup(X)(p11.22-p11.23) associated with mental retardation, speech delay, and EEG anomalies in males and females |
Q28752220 | Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies |
Q42249306 | Copy number variants in a sample of patients with psychotic disorders: is standard screening relevant for actual clinical practice? |
Q24630191 | Cutaneous features in 17q21.31 deletion syndrome: a differential diagnosis for cardio-facio-cutaneous syndrome |
Q26744182 | Cytogenomic Aberrations in Congenital Cardiovascular Malformations |
Q34288731 | De novo mutations in human genetic disease |
Q57990805 | De novo triplication of theMAPTgene from the recurrent 17q21.31 microdeletion region in a patient with moderate intellectual disability and various minor anomalies |
Q38068938 | Detection and interpretation of genomic structural variation in health and disease. |
Q30886605 | Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridization |
Q37499225 | Duplication hotspots, rare genomic disorders, and common disease |
Q47579952 | Early speech development in Koolen de Vries syndrome limited by oral praxis and hypotonia |
Q37784961 | Epigenetics, Copy Number Variation, and Other Molecular Mechanisms Underlying Neurodevelopmental Disabilities: New Insights and Diagnostic Approaches |
Q47696253 | Evaluation of PRDM9 variation as a risk factor for recurrent genomic disorders and chromosomal non-disjunction |
Q50640120 | Family based genome-wide copy number scan identifies complex rearrangements at 17q21.31 in dyslexics. |
Q37945467 | Functional enrichment analysis with structural variants: pitfalls and strategies |
Q47070224 | GATAD2B loss-of-function mutations cause a recognisable syndrome with intellectual disability and are associated with learning deficits and synaptic undergrowth in Drosophila. |
Q90669133 | Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association |
Q38112901 | Genetic architecture of reciprocal CNVs |
Q38233866 | Genetics and genomics of Parkinson's disease |
Q41929373 | Genome-wide mapping of copy number variations in patients with both anorectal malformations and central nervous system abnormalities |
Q37198442 | Genomic disorders ten years on. |
Q33937230 | Genomics, intellectual disability, and autism |
Q37654549 | Genotype to phenotype-discovery and characterization of novel genomic disorders in a "genotype-first" era. |
Q90139882 | Human core duplicon gene families: game changers or game players? |
Q22065433 | Human genome sequencing in health and disease |
Q33387075 | Identification of ANKRD11 and ZNF778 as candidate genes for autism and variable cognitive impairment in the novel 16q24.3 microdeletion syndrome. |
Q57150513 | Identification of copy number variants associated with BPES-like phenotypes |
Q52912983 | Intragenic KANSL1 mutations and chromosome 17q21.31 deletions: broadening the clinical spectrum and genotype-phenotype correlations in a large cohort of patients. |
Q88732265 | Inversion variants in human and primate genomes |
Q35751744 | KANSL1 gene disruption associated with the full clinical spectrum of 17q21.31 microdeletion syndrome |
Q47553892 | KANSL1 variation is not a major contributing factor in self-limited focal epilepsy syndromes of childhood |
Q38166377 | LIS1 and DCX: Implications for Brain Development and Human Disease in Relation to Microtubules. |
Q53150475 | Maternal intrachromosomal insertional translocation leads to recurrent 1q21.3q23.3 deletion in two siblings. |
Q93096067 | Menkes disease complicated by concurrent Koolen-de Vries syndrome (17q21.31 deletion) |
Q54408863 | Microdeletions of 3p21.31 characterized by developmental delay, distinctive features, elevated serum creatine kinase levels, and white matter involvement. |
Q42916354 | Molecular Characterization of Koolen De Vries Syndrome in Two Girls with Idiopathic Intellectual Disability from Central Brazil |
Q64994553 | Molecular Mechanisms of Syndromic Cryptorchidism: Data Synthesis of 50 Studies and Visualization of Gene-Disease Network. |
Q37185997 | Molecular and clinical delineation of the 17q22 microdeletion phenotype |
Q88038924 | Monozygotic twins with 17q21.31 microdeletion syndrome |
Q63432936 | Multi-platform discovery of haplotype-resolved structural variation in human genomes |
Q55670707 | Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype |
Q51788691 | Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. |
Q96431622 | Neural metabolic imbalance induced by MOF dysfunction triggers pericyte activation and breakdown of vasculature |
Q28073446 | New insights into the generation and role of de novo mutations in health and disease |
Q26995476 | Of mice and men: molecular genetics of congenital heart disease |
Q35226155 | On the sequence-directed nature of human gene mutation: the role of genomic architecture and the local DNA sequence environment in mediating gene mutations underlying human inherited disease |
Q50303585 | Outcome of array CGH analysis for 255 subjects with intellectual disability and search for candidate genes using bioinformatics. |
Q36486642 | Perspectives on stress resilience and adolescent neurobehavioral function |
Q35030847 | Phenotype mining in CNV carriers from a population cohort |
Q35892626 | Phenotypic information in genomic variant databases enhances clinical care and research: the International Standards for Cytogenomic Arrays Consortium experience |
Q38089841 | Prenatal diagnosis by array-comparative genomic hybridization |
Q36504775 | Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis. |
Q41842853 | Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region |
Q88580639 | Pronounced maternal parent-of-origin bias for type-1 NF1 microdeletions |
Q52320476 | RASopathies are associated with a distinct personality profile. |
Q34328409 | Recurrent copy number changes in mentally retarded children harbour genes involved in cellular localization and the glutamate receptor complex |
Q24633748 | Recurrent inversion events at 17q21.31 microdeletion locus are linked to the MAPT H2 haplotype |
Q29544005 | Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size |
Q53426251 | Recurrent reciprocal copy number variants: Roles and rules in neurodevelopmental disorders. |
Q30566015 | SNP arrays: comparing diagnostic yields for four platforms in children with developmental delay |
Q93043682 | Structural Genome Variations Related to Craniosynostosis |
Q36129488 | Structural diversity and African origin of the 17q21.31 inversion polymorphism |
Q45423315 | Syndromic Craniosynostosis Can Define New Candidate Genes for Suture Development or Result from the Non-specifc Effects of Pleiotropic Genes: Rasopathies and Chromatinopathies as Examples. |
Q48756991 | Tau's role in the developing brain: implications for intellectual disability. |
Q30477238 | The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype |
Q37058516 | The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant. |
Q50306612 | The clinical utility of molecular karyotyping using high-resolution array-comparative genomic hybridization. |
Q47740737 | The epileptology of Koolen-de Vries syndrome: Electro-clinico-radiologic findings in 31 patients |
Q33965270 | The genetic variability and commonality of neurodevelopmental disease |
Q35765523 | The genetics of microdeletion and microduplication syndromes: an update. |
Q58617586 | The many lives of KATs - detectors, integrators and modulators of the cellular environment |
Q34694730 | The phenotype of recurrent 10q22q23 deletions and duplications |
Q37445023 | The prevalence of chromosomal deletions relating to developmental delay and/or intellectual disability in human euploid blastocysts |
Q36035703 | Two families with sibling recurrence of the 17q21.31 microdeletion syndrome due to low-grade mosaicism |
Q38728734 | When the face says it all: dysmorphology in identifying syndromic causes of epilepsy |
Search more.